{"schema_version":"secwatch.filing_event.v1","accession":"0000818479-23-000026","form_type":"8-K","ticker":"XRAY","cik":"0000818479","company_name":"DENTSPLY SIRONA Inc.","filed_at":"2023-04-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.349265+00:00","generated_at":"2026-06-17T03:24:47.605028+00:00","sec_items":["5.02","7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Director Groetelaars not seeking re-election; IDEXX CEO Mazelsky nominated to board","bullets":["Director John P. Groetelaars will not stand for re-election at the 2023 Annual Meeting, ending his term.","Board approved Jonathan J. Mazelsky, President and CEO of IDEXX Laboratories, as a director nominee.","Groetelaars previously served as Interim CEO; Chairman Brandt thanked him for his service.","Mazelsky has been President and CEO of IDEXX since October 2019."],"urls":{"canonical":"https://secwatch.observer/filing/0000818479-23-000026","json":"https://secwatch.observer/filing/0000818479-23-000026.json","markdown":"https://secwatch.observer/filing/0000818479-23-000026.md","text":"https://secwatch.observer/filing/0000818479-23-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000026/0000818479-23-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000026/xray-20230412.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T03:24:47.605028+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d242640146","claim":"John P. Groetelaars departed as Director at DENTSPLY SIRONA Inc..","evidence_excerpt":"On April 10, 2023, John P. Groetelaars notified the Board of Directors (the \"Board\") of DENTSPLY SIRONA Inc. (the \"Company\") of his intent not to stand for re-election as a Director of the Company upon expiration of his current term, which expires at the Company's 2023 Annual Meeting of Stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/818479/000081847923000026/0000818479-23-000026-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"not standing for re-election"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}